What is the recommended initial dosage of piperacillin/tazobactam for a patient with CrCl >40mL/min?

What is the recommended initial dosage of piperacillin/tazobactam for a patient with CrCl >40mL/min?

• A. 3.375 g IV Q6H
• B. 4.5 g IV Q6H
• C. 2.25 g q 6 h
• D. 4.5 g IM Q8H

Answer: (B)

The recommended initial dosage of piperacillin/tazobactam for a patient with a creatinine clearance (CrCl) greater than 40 mL/min is indeed 4.5 g IV every 6 hours. This dosage is often used in clinical settings for the treatment of various serious infections due to its broad-spectrum activity against Gram-positive and Gram-negative bacteria, as well as anaerobes. The rationale behind this specific dosage is based on the need for effective antimicrobial coverage while ensuring adequate drug concentration in the body to combat the infection. The dosing schedule allows for the maintenance of therapeutic levels of the antibiotic in the system, which is crucial for its efficacy. Higher doses, such as 4.5 g, cater to more severe infections or those that are caused by resistant organisms, necessitating a more aggressive approach. It is important to note that piperacillin/tazobactam is typically administered intravenously in acute care settings to achieve rapid and high serum concentrations, especially in critically ill patients or those with severe pneumonia, sepsis, or intra-abdominal infections. In contrast, other dosages, like 3.375 g, may be used in different scenarios or for less severe infections, while an IM route

The recommended initial dosage of piperacillin/tazobactam for a patient with a creatinine clearance (CrCl) greater than 40 mL/min is indeed 4.5 g IV every 6 hours. This dosage is often used in clinical settings for the treatment of various serious infections due to its broad-spectrum activity against Gram-positive and Gram-negative bacteria, as well as anaerobes.

The rationale behind this specific dosage is based on the need for effective antimicrobial coverage while ensuring adequate drug concentration in the body to combat the infection. The dosing schedule allows for the maintenance of therapeutic levels of the antibiotic in the system, which is crucial for its efficacy.

Higher doses, such as 4.5 g, cater to more severe infections or those that are caused by resistant organisms, necessitating a more aggressive approach. It is important to note that piperacillin/tazobactam is typically administered intravenously in acute care settings to achieve rapid and high serum concentrations, especially in critically ill patients or those with severe pneumonia, sepsis, or intra-abdominal infections.

In contrast, other dosages, like 3.375 g, may be used in different scenarios or for less severe infections, while an IM route